Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 45(13): 2417-2419, 2018 Dec.
Article in Japanese | MEDLINE | ID: mdl-30692483

ABSTRACT

We report a case of unresectable pancreas cancer. A 70-year-old woman presented with worsening diabetes and serum CA19-9 elevation. A tumor with portal vein and supra-mesenteric vein invasion was observed by computed tomography. She was diagnosed with unresectable pancreas head cancer that was locally advanced. Chemotherapy was administered with gemcitabine and nab-paclitaxel for 19 courses, followed by gemcitabine alone for 4 courses. After the addition of 6 courses of chemotherapy, a 60%dose of chemotherapy was administered for 13 courses due to severe neutropenia. The patient died 32 months after the first visit. The 60% dose of gemcitabine and nab-paclitaxel also inhibited tumor growth. These findings suggest the effective and safe long-term use of gemcitabine and nab-paclitaxel.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols , Pancreatic Neoplasms , Aged , Albumins , CA-19-9 Antigen/blood , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Female , Humans , Paclitaxel/administration & dosage , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/drug therapy , Tomography, X-Ray Computed , Gemcitabine
SELECTION OF CITATIONS
SEARCH DETAIL
...